Creative Medical Technology Holdings, Inc. (CELZ)
Nasdaq: CELZ · Biological Products, (No Diagnostic Substances) · Phoenix, AZ · filing with the SEC since 2002
Who owns Creative Medical Technology Holdings, Inc.
As filed with the SECHolders of 5% or more
1
Timothy Warbington holds 13.7% of Common Stock, par value $0.001 per share, as its SCHEDULE 13D filed Oct 1, 2026 says.
Directors and officers
2
report now, of 9 people on the record since 2009. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Timothy Warbington
SCHEDULE 13D · filed Oct 1, 2026 · Common Stock, par value $0.001 per share
Armistice Capital, LLC
SCHEDULE 13G/A · filed Aug 14, 2025 · Common Stock, par value $0.001 per share · reported falling below 5%, from 5.72% in May 15, 2025
What CELZ reports owning in othersstakes of 5% or more, and other ties
6 subsidiaries in 1 country, from the list filed with the 10-K filed Mar 20, 2026.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2025 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.